Penumbra Inc (PEN)
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Penumbra, Inc.
NYSE:PENHealthcare · Medical - Devices
-0.18%$324.39
AH Close$324.39+0.00%vs close
AH Close$324.39+0.00%vs close
Mkt Cap$12.78B
Float38.23M
O/S39.39M
Inst Own86.6%
SI5.9%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$1.4B
Net Income$177.69M
Total Assets$1.83B
Free Cash Flow$174.93M
Debt & Equity
Debt 13%
Equity 87%
Total Debt$219.7M
Total Equity$1.43B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in PEN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.83B
Liabilities$398.92M
Accounts Receivable$190.02M
Accounts Payable$34.74M
Inventory$431.55M
PP&E (Net)$316.35M
Goodwill$166.75M
Intangible Assets$6.83M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $1.4B | $1.19B | $1.06B | $847.13M | $747.59M | $560.41M | $547.4M | $444.94M | $333.76M | $263.32M | $186.09M | $125.51M | $88.85M | $73.14M |
| YoY Growth | 17.5% | 12.9% | 25.0% | 13.3% | 33.4% | 2.4% | 23.0% | 33.3% | 26.8% | 41.5% | 48.3% | 41.3% | 21.5% | - |
| Cost of Revenue | $461.23M | $439.62M | $375.88M | $311.93M | $272.21M | $222.24M | $175.44M | $152.41M | $116.62M | $92.49M | $62.04M | $42.67M | $30.97M | $24.18M |
| Gross Profit | $942.44M | $755M | $682.64M | $535.21M | $475.38M | $338.18M | $371.96M | $292.53M | $217.14M | $170.83M | $124.06M | $82.84M | $57.88M | $48.96M |
| Gross Margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | 65.7% | 65.1% | 64.9% | 66.7% | 66.0% | 65.1% | 66.9% |
| Research and Development | $89.77M | $94.78M | $84.42M | $79.41M | $104.55M | $90.05M | $51.72M | $36.16M | $31.66M | $23.88M | $18.03M | $15.57M | $14.08M | $12.55M |
| Selling, General, and Administrative | $663.42M | $573.99M | $506.45M | $449.72M | $378.33M | $287.07M | $272.73M | $226.38M | $184.32M | $148.3M | $101.85M | $64.26M | $44.92M | $32.99M |
| Other | $0 | $0 | $18.21M | $0 | $0 | $0 | $0 | $30.84M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $753.19M | $668.77M | $609.09M | $529.13M | $482.88M | $377.12M | $324.46M | $293.38M | $215.98M | $172.18M | $119.88M | $79.83M | $59M | $45.53M |
| Operating Income (EBIT) | $189.25M | $86.22M | $73.55M | $6.08M | -$7.5M | -$38.94M | $47.51M | -$852K | $1.17M | -$1.35M | $4.18M | $3.01M | -$1.13M | $3.43M |
| Operating Margin | 13.5% | 7.2% | 6.9% | 0.7% | -1.0% | -6.9% | 8.7% | -0.2% | 0.3% | -0.5% | 2.2% | 2.4% | -1.3% | 4.7% |
| Interest Expense | $1.31M | $1.42M | $1.74M | $1.75M | $1.93M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $16.29M | $13.69M | $6.83M | $1.89M | $2.87M | $1.27M | $2.85M | $2.96M | $2.65M | $2.32M | $541K | $439K | $345K | $244K |
| Other Income (Expense) | $15.88M | -$65.36M | $6.1M | -$2.19M | -$3M | $924K | $2.63M | $2.46M | $1.31M | $481K | -$155K | $130K | -$129K | $464K |
| Income Before Tax (EBT) | $205.13M | $20.87M | $79.65M | $3.89M | -$10.5M | -$38.02M | $50.13M | $1.61M | $2.48M | -$869K | $4.02M | $3.14M | -$1.25M | $3.89M |
| Income Tax Expense | $27.44M | $6.86M | -$11.3M | $5.89M | -$13.13M | -$18.76M | $3.13M | -$4.4M | -$3.61M | -$15.68M | $1.66M | $894K | -$5.35M | $1.93M |
| Net Income | $177.69M | $14.01M | $90.95M | -$2M | $5.28M | -$15.7M | $48.46M | $6.6M | $4.66M | $14.81M | $2.37M | $2.25M | $4.1M | $1.96M |
| Net Income Margin | 12.7% | 1.2% | 8.6% | -0.2% | 0.7% | -2.8% | 8.9% | 1.5% | 1.4% | 5.6% | 1.3% | 1.8% | 4.6% | 2.7% |
| Supplementary Data | ||||||||||||||
| EPS | 4.57 | 0.36 | 2.37 | -0.05 | 0.14 | -0.54 | 1.39 | 0.18 | 0.14 | 0.49 | 0.09 | -0.03 | 0.04 | 0.08 |
| Diluted EPS | 4.52 | 0.36 | 2.32 | -0.05 | 0.14 | -0.54 | 1.34 | 0.18 | 0.13 | 0.44 | 0.08 | -0.03 | 0.04 | 0.08 |
| Weighted Average OS | 38.92M | 38.63M | 38.40M | 37.84M | 36.76M | 35.77M | 34.75M | 36.09M | 32.98M | 30.46M | 11.99M | 24.51M | 24.51M | 24.51M |
| EBITDA | $223.91M | $45.99M | $108.65M | $29.96M | $7.84M | -$26.05M | $55.61M | $36.15M | $4.95M | $947K | $5.93M | $3.76M | -$449K | $3.43M |
| EBITDA Margin | 16.0% | 3.8% | 10.3% | 3.5% | 1.0% | -4.6% | 10.2% | 8.1% | 1.5% | 0.4% | 3.2% | 3.0% | -0.5% | 4.7% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $186.9M | $324.4M | $167.49M | $69.86M | $59.38M | $69.67M | $72.78M | $67.85M | $50.64M | $13.24M | $19.55M | $3.29M | $4.13M |
| Short-Term Investments | $357.92M | $15.73M | $121.7M | $118.17M | $195.5M | $195.16M | $116.61M | $133.04M | $163.95M | $115.52M | $129.26M | $48.25M | $9.54M |
| Cash and Short-Term Investments | $544.82M | $340.13M | $289.19M | $188.03M | $254.88M | $264.83M | $189.39M | $200.89M | $214.59M | $128.75M | $148.8M | $51.54M | $13.68M |
| Accounts Receivable | $190.02M | $167.67M | $201.77M | $203.38M | $133.94M | $114.61M | $105.9M | $81.9M | $58.01M | $43.34M | $29.44M | $20.57M | $13.15M |
| Inventory | $431.55M | $406.74M | $388.02M | $334.01M | $263.5M | $219.53M | $152.99M | $115.74M | $94.9M | $73.01M | $56.76M | $33.45M | $27.07M |
| Other Current Assets | $50.3M | $36.59M | $36.42M | $30.28M | $2.4M | $0 | $0 | $0 | $0 | $9.5M | $1.3M | $6.61M | $5.18M |
| Total Current Assets | $1.22B | $951.13M | $915.4M | $755.7M | $681.47M | $617.7M | $463.13M | $410.73M | $382.23M | $263.83M | $244.36M | $115.3M | $62.24M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $316.35M | $267.76M | $280.5M | $280.41M | $227.09M | $127.43M | $135.45M | $35.41M | $30.9M | $21.46M | $8.95M | $5.18M | $2.03M |
| Goodwill | $166.75M | $165.83M | $166.27M | $166.05M | $166.39M | $8.37M | $7.66M | $7.81M | $8.18M | $0 | $0 | $0 | $0 |
| Intangible Assets | $6.83M | $7.2M | $83.09M | $91.72M | $90.62M | $10.64M | $25.41M | $27.25M | $23.78M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.87M | $0 | $5K | $0 | $6M |
| Deferred Tax Assets | $79.19M | $100.33M | $85.16M | $64.21M | $65.7M | $50.14M | $31.3M | $32.94M | $26.69M | $22.48M | $10.14M | $571K | $424K |
| Other Long-Term Assets | $40.72M | $40.94M | $25.88M | $12.79M | $12.98M | $8.71M | $2.95M | $875K | $1.02M | $487K | $393K | $328K | $454K |
| Total Long-Term Assets | $609.84M | $582.06M | $640.9M | $615.19M | $562.78M | $205.28M | $202.77M | $104.28M | $94.43M | $44.43M | $19.49M | $6.08M | $8.91M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $822.98M | $665.9M | $515.01M | $476.67M | $308.25M | $263.85M | $121.38M | $71.15M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $34.74M | $31.33M | $27.16M | $26.68M | $13.42M | $14.11M | $15.11M | $8.18M | $6.76M | $4.11M | $2.57M | $2.35M | $1.31M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $907K | $839K | $638K | $368K |
| Current Unearned Revenue | $0 | $940K | $6.99M | $9.16M | $0 | $0 | $0 | $0 | $0 | $344K | $526K | $1.59M | $1.09M |
| Other Current Liabilities | $0 | -$940K | $0 | $0 | $0 | $9.81M | $1.82M | $9.3M | $8.88M | $14.39M | $10.56M | $8.03M | $7.95M |
| Total Current Liabilities | $183.13M | $158.34M | $151.14M | $144.93M | $123.2M | $105.93M | $91.05M | $66.06M | $51.58M | $35.8M | $28.15M | $20.82M | $15.84M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $4.78M | $4M | $4.17M | $3.3M | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $12.32M | $15.11M | $5.31M | $3.28M | $3.56M | $3.23M | $11.24M | $22.36M | $21.38M | $5.91M | $3.18M | $112.93M | $57.37M |
| Total Long-Term Liabilities | $215.78M | $223.91M | $226.22M | $227.1M | $167.13M | $79.26M | $89.24M | $26.53M | $24.68M | $5.91M | $3.18M | $112.93M | $63.37M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $398.92M | $382.25M | $377.36M | $372.03M | $290.32M | $185.19M | $180.29M | $92.59M | $76.26M | $41.71M | $31.33M | $133.75M | $79.21M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $431K | $0 | $0 | $111.47M | $56.22M |
| Common Stock | $39K | $38K | $39K | $38K | $37K | $36K | $35K | $34K | $33K | $31K | $30K | $5K | $4K |
| Retained Earnings | $237.69M | $60M | $134.86M | $43.9M | $45.91M | $40.62M | $57.52M | $9.06M | $2M | -$2.66M | -$17.48M | -$19.84M | -$14.99M |
| Comprehensive Income & Other | $4.35M | -$5.84M | -$3.15M | -$8.12M | -$2.63M | $2.54M | -$2.32M | -$1.94M | $1.57M | -$4.69M | -$2.12M | -$864K | $796K |
| Other Stockholders' Equity | $1.19B | $1.09B | $1.04B | $954.92M | $907.98M | $600.84M | $428.33M | $413.14M | $398.38M | $269.18M | $249.97M | $7.46M | $6.93M |
| Total Equity | $1.43B | $1.15B | $1.18B | $998.86M | $953.93M | $641.5M | $485.89M | $422.24M | $400.41M | $266.55M | $232.52M | -$12.37M | -$8.06M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | -$3.71M | -$279K | $175K | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $826.69M | $666.18M | $514.83M | $476.67M | $308.25M | $263.85M | $121.38M | $71.15M |
| Supplementary Data | |||||||||||||
| Total Debt | $219.7M | $223.39M | $234.34M | $235.77M | $173.55M | $77.28M | $82.3M | $0 | $0 | $0 | $0 | $0 | $6M |
| Net Debt | $32.8M | -$101.02M | $66.86M | $165.91M | $114.17M | $7.61M | $9.52M | -$67.85M | -$50.64M | -$13.24M | -$19.55M | -$3.29M | $1.87M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | $177.69M | $14.01M | $90.95M | -$2M | $5.28M | -$19.26M | $48.46M | $2.91M | $4.66M | $14.81M | $2.37M | $2.25M | $4.1M |
| Depreciation & Amortization | $17.47M | $23.7M | $27.26M | $24.32M | $16.41M | $12.89M | $8.1M | $6.17M | $3.78M | $2.3M | $1.75M | $751K | $677K |
| Deferred Income Tax | $21.03M | -$16.34M | -$19.06M | $1.46M | -$14.09M | -$18.82M | $1.82M | -$6.48M | -$4.29M | -$12.38M | -$2.96M | -$571K | -$335K |
| Stock-Based Compensation | $59.21M | $46.16M | $0 | $0 | $0 | $25.54M | $0 | $18.42M | $17.81M | $14.64M | $7.27M | $1.43M | $886K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | -$19.51M | $26.6M | -$266K | -$69.86M | -$21.34M | -$8.29M | -$25.03M | -$25.76M | -$9.12M | -$14.56M | -$11.06M | -$7.43M | -$1.55M |
| Inventory | -$26.48M | -$65.66M | -$67.71M | -$74.63M | -$51.55M | -$56.98M | -$41.41M | -$22.29M | -$18.83M | -$19.74M | -$25.13M | -$9.44M | -$3.78M |
| Accounts Payable | $3.07M | $4.17M | $1.1M | $13.38M | -$1.56M | -$308K | $6.04M | $1.33M | $1.85M | $1.38M | $132K | $1.3M | -$451K |
| Other Working Capital | $213K | $11.11M | -$12.21M | $9.57M | $7.75M | $14.39M | $3.56M | $16.46M | $12.6M | -$3.27M | $3.79M | $3.46M | $785K |
| Total Working Capital Change | -$42.72M | -$23.78M | -$79.08M | -$121.53M | -$66.71M | -$51.19M | -$56.84M | -$30.26M | -$13.49M | -$36.19M | -$32.26M | -$12.11M | -$5M |
| Other Non-Cash Items | $5.97M | $124.72M | $77.27M | $42.1M | $68.61M | $17.59M | $25.11M | $38.05M | $4.22M | $4.01M | $1.56M | $1.86M | -$3.73M |
| Net Cash from Operating | $238.66M | $168.48M | $97.33M | -$55.66M | $9.5M | -$33.24M | $26.65M | $28.81M | $12.69M | -$12.81M | -$22.28M | -$6.39M | -$3.4M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$63.73M | -$21.18M | -$15.21M | -$19.3M | -$21.18M | -$24.76M | -$22.11M | -$9.6M | -$15.03M | -$13.63M | -$5.47M | -$3.89M | -$798K |
| Acquisitions | $0 | $0 | -$988K | $0 | $2.92M | $0 | $800K | -$20.41M | -$9.25M | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$355.74M | -$32.91M | -$81.94M | $0 | -$126.79M | -$153.06M | -$77.33M | -$109.61M | -$194.92M | -$63.35M | -$135.34M | -$51.34M | -$6.86M |
| Sales of Investments | $14.88M | $130.62M | $82.56M | $74.09M | $123.72M | $76.73M | $95.36M | $139.24M | $141.56M | $77.67M | $55M | $18.23M | $6.41M |
| Other Investing Activities | $0 | $1.1M | -$500K | $0 | -$400K | -$3.06M | -$8.64M | $29.63M | -$55.87M | $14.32M | -$80.34M | -$33.11M | -$453K |
| Net Cash from Investing | -$404.59M | $77.62M | -$16.08M | $54.79M | -$21.73M | -$104.15M | -$11.91M | -$385K | -$77.65M | $687K | -$85.82M | -$37M | -$1.25M |
| Financing Activities | |||||||||||||
| Debt Repaid | $2.48M | $2.28M | $1.98M | $1.75M | $1.45M | $3.42M | $2.57M | $404K | $1.08M | - | - | $6M | -$2M |
| Common Stock Issuance | $31.82M | $17.17M | $20.41M | $21.55M | $18.37M | $134.76M | $13.1M | $7.23M | $106.27M | $6.58M | $124.74M | $0 | $0 |
| Common Stock Repurchases | $0 | -$100.39M | $0 | $0 | $0 | $0 | $0 | -$17.73M | $0 | -$2.62M | $0 | -$9.35M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$2.8M | -$1.52M | -$2.23M | -$8.18M | -$16.08M | $3.58M | -$20.29M | -$9.41M | -$829K | $7.13M | -$318K | $1.04M | $178K |
| Net Cash from Financing | $26.53M | -$87.01M | $16.2M | $11.62M | $836K | $134.92M | -$9.76M | -$9.81M | $104.36M | $7.13M | $124.42M | $42.9M | $2.18M |
| Forex Effect | $1.89M | -$2.18M | $168K | -$272K | $1.11M | -$635K | -$53K | -$1.4M | -$2M | -$1.32M | -$72K | -$348K | -$835K |
| Net Change in Cash | -$137.51M | $156.92M | $97.63M | $10.48M | -$10.29M | -$3.11M | $4.93M | $17.21M | $37.4M | -$6.31M | $16.26M | -$841K | -$3.3M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | $238.66M | $168.48M | $97.33M | -$55.66M | $9.5M | -$33.24M | $26.65M | $28.81M | $12.69M | -$12.81M | -$22.28M | -$6.39M | -$3.4M |
| Capital Expenditure | -$63.73M | -$21.18M | -$15.21M | -$19.3M | -$21.18M | -$24.76M | -$22.11M | -$9.6M | -$15.03M | -$13.63M | -$5.47M | -$3.89M | -$798K |
| Free Cash Flow | $174.93M | $147.3M | $82.12M | -$74.96M | -$11.68M | -$58M | $4.54M | $19.2M | -$2.34M | -$26.44M | -$27.75M | -$10.28M | -$4.19M |
| Cash at Beginning | $324.4M | $167.49M | $69.86M | $59.38M | $69.67M | $72.78M | $67.85M | $50.64M | $13.24M | $19.55M | $3.29M | $4.13M | $7.43M |
| Cash at End | $186.9M | $324.4M | $167.49M | $69.86M | $59.38M | $69.67M | $72.78M | $67.85M | $50.64M | $13.24M | $19.55M | $3.29M | $4.13M |